Nutraceutix Inc. Makes Available for the First Time D-Glucarate With Patented Controlled Delivery Technology.

Health & Medical Writers

REDMOND, Wash.--(BW HealthWire)--March 21, 2001

Nutraceutix Inc. (OTC BB: NUTX) introduces for the first time to the nutritional supplement market D-Glucarate Pre-Blend with patented Controlled Delivery Technology (CDT)(TM).

Now manufacturers can pass along to their consumers the healthful benefits of patented Calcium D-Glucarate with the controlled dosage and release of patented CDT(TM). Nutraceutix Inc. offers CDT(TM) D-Glucarate with 12-hour release and CDT(TM) D-Glucarate with 24-hour release in 200mg tablets.

D-Glucarate is the patented form of glucaric acid, a naturally occurring substance in the body that promotes glucuronidation, a process by which the body eliminates toxins. While glucaric acid is found primarily in fruits and cruciferous vegetables, numerous studies indicate that increased levels of D-Glucarate through supplementation are effective in assisting the body in detoxification.

D-Glucarate research has proven so promising that internationally recognized AMC Cancer Research Center, Denver has recommended D-Glucarate's use; the first time the not-for-profit research institution has recommended a dietary supplement.

According to Nutraceutix President and Chief Executive Officer, David Howard, "CDT(TM) D-Glucarate is the third in our series of patented nutraceutical pre-blends. As more consumers learn the credible health benefits of D-Glucarate, the demand will grow accordingly. CDT(TM) D-Glucarate Pre-Blend allows our manufacturing partners easy-to-use formulations that are safe and efficacious to consumers.

"Patented D-Glucarate Pre-Blend with the added advantage of CDT(TM)'s optimal delivery mechanism add up to a winning combination."

Currently, Nutraceutix Inc. has licensed the use of Calcium D-Glucarate to more than 40 different companies. Glucona America Inc. of Janesville, Wis., master supplier of D-Glucarate, has developed and implemented a proprietary identification marker in its continuing campaign to protect patented Calcium D-Glucarate from distribution by unlicensed distributors.

The marker creates a chemical "fingerprint" that allows the company to accurately and definitively identify its product. This practice reduces the likelihood of fraudulent and inferior product entering the market and reaching consumers.

Nutraceutix Inc. possesses proven technologies and products for the nutraceutical industry. In addition to patented ingredients like Calcium D-Glucarate(TM), Nutraceutix provides patented and proprietary technologies like CDT(TM) Controlled Delivery Technology, MDT(TM) Molecular Dispersion Technology, SET(TM) Self Emulsifying Technology and LiveBac(R) Probiotics.

Nutraceutix technologies provide distinctive supplements with tangible benefits for the consumer and competitive commercial advantages. For more information on Nutraceutix, please call Stephen Turner, director, Project Management at 800/548-3222, or visit www.nutraceutix.com.

Except for any historical information, the matters discussed in this press release contain forward-looking statements, including activities, events or developments that the company expects, believes or anticipates will or may occur in the future. Such statements are subject to a number of assumptions, risks and uncertainties.

Readers are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statements.